Ali Saifi, MD
NPI 1376530303 · Internal Medicine Physician · Clearwater, FL
Enrolled with Medicare as Practitioner - Internal Medicine · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1376530303
- Entity type
- Individual
- Primary specialty
- Internal Medicine PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- ME0071116 (FL)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
3,449 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 625 | $88 |
| Insertion of Needle Into Vein for Collection of Blood Sample36415 | 429 | $9 |
| Hemoglobin A1c Level83036 | 397 | $10 |
| Blood Glucose (sugar) Test Performed By Hand-Held Instrument82962 | 247 | $3 |
| Advance Care Planning, First 30 Minutes99497 | 227 | $79 |
| Urine Microalbumin (protein) Analysis82044 | 206 | $6 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 252 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Atorvastatin Calcium | 1,100 | 316 |
| Alprazolam | 984 | 169 |
| Levothyroxine Sodium | 743 | 196 |
| Amlodipine Besylate | 574 | 165 |
| Lisinopril | 565 | 166 |
| Rosuvastatin Calcium | 449 | 146 |
| Omeprazole |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$2,907 across 143 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-10-04
- Last updated
- 2008-06-17
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.